Aarti Pharmalabs Ltd. - Research Center
543748 AARTIPHARM Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | |
|---|---|---|
| Sales | 714.28 | 777.65 |
| Operating profit | 150.55 | 158.98 |
| Interest | 7.85 | 9.57 |
| Gross profit | 147.56 | 150.65 |
| EPS (Rs) | 9.87 | 10.28 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | |
|---|---|---|
| Other income | 4.86 | 1.24 |
| Stock adjustment | -25.40 | -73.26 |
| Raw material | 390.52 | 494.88 |
| Power and fuel | - | - |
| Employee expenses | 61.37 | 58.33 |
| Excise | - | - |
| Admin and selling expenses | - | - |
| Research and development expenses | - | - |
| Expenses capitalised | - | - |
| Other expenses | 137.24 | 138.72 |
| Provisions made | - | - |
| Depreciation | 31.76 | 26.96 |
| Taxation | 26.36 | 30.50 |
| Net profit / loss | 89.44 | 93.19 |
| Extra ordinary item | - | - |
| Prior year adjustments | - | - |
| Equity capital | 45.31 | 45.31 |
| Equity dividend rate | - | - |
| Agg.of non-prom. shares (Lacs) | - | - |
| Agg.of non promotoholding (%) | - | - |
| OPM (%) | 21.08 | 20.44 |
| GPM (%) | 20.52 | 19.34 |
| NPM (%) | 12.44 | 11.96 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis